The extension of the collaboration is a natural way forward to continue driving innovation in the discovery and development of highly differentiated cancer therapeutics... Oct 30
Servier, an independent international pharmaceutical company, today announced the acquisition of PIXUVRI® from CTI BioPharma.... Oct 01
-Advertisements-